Raphaela Schwentner

1.5k citations

30 papers · 1.0k indexed · h-index 19

Impact in

Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 10%
- Sarcoma Diagnosis and Treatment

Papers in ⓘ

Molecular Biology 22
- RNA Research and Splicing 8
- RNA modifications and cancer 7
- Protein Degradation and Inhibitors 3
Physiology 9
- Histiocytic Disorders and Treatments 9

Co-authors: Heinrich Kovar (19 shared papers)Maximilian Kauer (14 shared papers)Gunhild Jug (9 shared papers)Dave N.T. Aryee (10 shared papers)Caroline Hutter (11 shared papers)Jozef Ban (6 shared papers)D N T Aryee (4 shared papers)Max Kauer (4 shared papers)
Journals: Cancer Research (5 papers)Oncotarget (4 papers)Oncogene (3 papers)Blood (3 papers)Blood Advances (2 papers)
Partner nations: Austria United States Slovakia

In The Last Decade

Raphaela Schwentner

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Raphaela Schwentner

Since Specialization

Citations

This map shows the geographic impact of Raphaela Schwentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaela Schwentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaela Schwentner more than expected).

Fields of papers citing papers by Raphaela Schwentner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaela Schwentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaela Schwentner. The network helps show where Raphaela Schwentner may publish in the future.

Co-authors

The 25 scholars most cited alongside Raphaela Schwentner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphaela Schwentner Line = papers co-authored together Raphaela Schwentner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer Genome Research ·Sven Bilke, Raphaela Schwentner, Fan Yang, Maximilian Kauer, Gunhild Jug, Robert L. Walker, Sean Davis, Yuelin J. Zhu, Marbin Pineda, Paul S. Meltzer, Heinrich Kovar	2013	80
2	EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma Cancer Research ·Jozef Ban, Idriss M. Bennani-Baı̈ti, Max Kauer, Karl‐Ludwig Schaefer, Christopher Poremba, Gunhild Jug, Raphaela Schwentner, Oskar W. Smrzka, Karin Muehlbacher, Dave N.T. Aryee, Heinrich Kovar	2008	79
3	Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts eLife ·Petra van der Lelij, Simone Lieb, Julian Jude, Gordana Wutz, Catarina P. Santos, Katrina J. Falkenberg, Andreas Schlattl, Jozef Ban, Raphaela Schwentner, Thomas Hoffmann, Heinrich Kovar, Francisco X. Real, Todd Waldman, Mark Pearson, Norbert Kraut, Jan‐Michael Peters, Johannes Zuber, Mark Petronczki	2017	79
4	Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma Oncogene ·J. Bán, Gunhild Jug, Pieter Mestdagh, Raphaela Schwentner, Maximilian Kauer, D N T Aryee, KL. SCHAEFER, Fumihiko Nakatani, Katia Scotlandi, Michael J. Reiter, Dirk Strunk, Frank Speleman, Jo Vandesompele, Heinrich Kovar	2011	77
5	Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells Blood ·Caroline Hutter, Max Kauer, Ingrid Simonitsch‐Klupp, Gunhild Jug, Raphaela Schwentner, Judith Leitner, Peter Böck, Peter Steinberger, Wolfgang Bauer, Nadia Carlesso, Milen Minkov, Helmut Gadner, Georg Stingl, Heinrich Kovar, Ernst Kriehuber	2012	68
6	Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis Journal of Molecular Diagnostics ·Teresa Gerber, Sabine Taschner‐Mandl, Lisa Saloberger-Sindhöringer, Niko Popitsch, Ellen Heitzer, Volker Witt, René Geyeregger, Caroline Hutter, Raphaela Schwentner, Inge M. Ambros, Peter F. Ambros	2020	58
7	Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro Cancer Research ·Dave N.T. Aryee, Stephan Niedan, Maximilian Kauer, Raphaela Schwentner, Idriss M. Bennani-Baı̈ti, Jozef Ban, Karin Muehlbacher, Michael Kreppel, Robert L. Walker, Paul S. Meltzer, Christopher Poremba, Reinhard Kofler, Heinrich Kovar	2010	57
8	Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma Cancer Research ·Jozef Ban, Dave N.T. Aryee, Argyro Fourtouna, Wietske van der Ent, Max Kauer, Stephan Niedan, Isidro Machado, Carlos Rodríguez‐Galindo, Òscar M. Tirado, Raphaela Schwentner, Piero Picci, Adrienne M. Flanagan, Verena Berg, Sandra J. Strauss, Katia Scotlandi, Elizabeth R. Lawlor, B. Ewa Snaar‐Jagalska, Antonio Llombart‐Bosch, Heinrich Kovar	2014	57
9	Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs Epigenetics ·Laurie K. Svoboda, Ashley Harris, Natashay J. Bailey, Raphaela Schwentner, Eleni M. Tomazou, Cornelia von Levetzow, Brian Magnuson, Mats Ljungman, Heinrich Kovar, Elizabeth R. Lawlor	2014	51
10	EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma Oncogene ·Anna M. Katschnig, Maximilian Kauer, Raphaela Schwentner, Eleni M. Tomazou, Cornelia Mutz, Markus Linder, Maria Sibilia, Javier Alonso, D N T Aryee, Heinrich Kovar	2017	41
11	Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma British Journal of Cancer ·D N T Aryee, Stephan Niedan, J. Bán, Raphaela Schwentner, Karin Muehlbacher, Maximilian Kauer, Reinhard Kofler, Heinrich Kovar	2013	40
12	Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis Cancer Discovery ·Florian Halbritter, Matthias Farlik, Raphaela Schwentner, Gunhild Jug, Nikolaus Fortelny, Thomas Schnöller, Hanja Pisa, Linda C. Schuster, Andrea Reinprecht, Thomas Czech, Johannes Gojo, Wolfgang Holter, Milen Minkov, Wolfgang Bauer, Ingrid Simonitsch‐Klupp, Christoph Bock, Caroline Hutter	2019	38
13	YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells Oncogenesis ·Lisa Bierbaumer, Anna M. Katschnig, Branka Radic-Sarikas, Maximilian Kauer, Jeffrey A. Petro, Sandra Högler, Elisabeth Gurnhofer, Gloria Pedot, Beat W. Schäfer, Raphaela Schwentner, Karin Mühlbacher, Florian Kromp, Dave N.T. Aryee, Lukas Kenner, Aykut Üren, Heinrich Kovar	2021	36
14	EWS-FLI1 employs an E2F switch to drive target gene expression Nucleic Acids Research ·Raphaela Schwentner, Theodore Papamarkou, Maximilian Kauer, Vassilios Stathopoulos, Fan Yang, Sven Bilke, Paul S. Meltzer, Mark Girolami, Heinrich Kovar	2015	34
15	Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma Oncogene ·Stephan Niedan, Maximilian Kauer, D N T Aryee, Reinhard Kofler, Raphaela Schwentner, Angelina Meier, Ulrike Pötschger, Udo Kontny, Heinrich Kovar	2013	33
16	Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature Oncotarget ·Anne Heisig, Jan Tind Sørensen, Stefanie Zimmermann, Stefan Schöning, Dirk Schwabe, Hans Michael Kvasnicka, Raphaela Schwentner, Caroline Hutter, Thomas Lehrnbecher	2018	27
17	Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH Blood Advances ·Alexandra Kolenová, Raphaela Schwentner, Gunhild Jug, Ingrid Simonitsch‐Klupp, Christoph Kornauth, Lukáš Plank, Júlia Horáková, Ivana Boďová, Tomáš Sýkora, Lucia Geczová, Wolfgang Holter, Milen Minkov, Caroline Hutter	2017	26
18	EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells Oncotarget ·Cornelia Mutz, Raphaela Schwentner, Dave N.T. Aryee, Eric D.J. Bouchard, Edgard M. Mejia, Grant M. Hatch, Maximilian Kauer, Anna M. Katschnig, Jozef Ban, Antje Garten, Javier Alonso, Versha Banerji, Heinrich Kovar	2017	21
19	Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis Pediatric Research ·Raphaela Schwentner, Alexandra Kolenová, Gunhild Jug, Thomas Schnöller, Martina Ahlmann, Bernhard Meister, Thomas Lehrnbecher, Milen Minkov, Caroline Hutter	2018	18
20	JAG2 signaling induces differentiation of CD14+ monocytes into Langerhans cell histiocytosis-like cells Journal of Leukocyte Biology ·Raphaela Schwentner, Gunhild Jug, Maximilian Kauer, Thomas Schnöller, Petra Waidhofer‐Söllner, Wolfgang Holter, Caroline Hutter	2018	18

About Raphaela Schwentner

Raphaela Schwentner is a scholar working on Molecular Biology, Physiology, Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Histiocytic Disorders and Treatments (9 papers), RNA Research and Splicing (8 papers), Sarcoma Diagnosis and Treatment (7 papers), RNA modifications and cancer (7 papers), Mast cells and histamine (4 papers), Protein Degradation and Inhibitors (3 papers), interferon and immune responses (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (276 citations), Pulmonary and Respiratory Medicine (344 citations), Molecular Biology (565 citations), Oncology (222 citations) and Physiology (186 citations). Raphaela Schwentner has collaborated with scholars based in Austria, United States and Slovakia. Frequent co-authors include Heinrich Kovar, Maximilian Kauer, Gunhild Jug, Dave N.T. Aryee, Caroline Hutter, Jozef Ban, D N T Aryee, Max Kauer, Paul S. Meltzer and Milen Minkov. Their work appears in journals such as Cancer Research, Oncotarget, Oncogene, Blood and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact